We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Grants Breakthrough Designation for Multiple Myeloma Drug

News   May 20, 2014

 
FDA Grants Breakthrough Designation for Multiple Myeloma Drug
 
 
 

RELATED ARTICLES

When Studying Immune Cells, Environment Matters

News

A new report recommends that looking outside the dish and into living organisms gives an improved understanding of the way immune cells process and use energy.

READ MORE

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

Cancer Risk Increases If Overweight Before 40

News

New research has demonstrated that overweight and adults have an increased risk of postmenopausal breast, endometrial, renal-cell and colon cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE